Literature DB >> 2188719

Ceftizoxime: a third-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2188719      PMCID： PMC1452577     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  33 in total

1.  Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, beta-lactamase stability, and inhibition.

Authors:  A L Barry; R N Jones; C Thornsberry; P C Fuchs; E H Gerlach; H M Sommers
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

2.  Comparative tissue and extravascular fluid concentrations of ceftizoxime.

Authors:  D N Gerding; L R Peterson
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

3.  Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans.

Authors:  R Quintiliani; C H Nightingale
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

4.  Pharmacokinetics of ceftizoxime.

Authors:  R E Cutler; A D Blair; E D Burgess; D Parks
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

5.  Ceftizoxime in the treatment of urinary tract infection in spinal cord injury patients: comparison with tobramycin.

Authors:  J Z Montgomerie; J W Morrow; H N Canawati; D S Gilmore; E M Jiminez; G M Malik
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

6.  Use of ceftizoxime in the treatment of paediatric infections.

Authors:  C M Shikuma; D C Cable; G Edralin; G D Overturf
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

7.  Ceftizoxime compared with cefamandole for treatment of soft tissue infections.

Authors:  J Mills; G Slutkin; D Klein; W Schecter
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

8.  Factors that affect the in-vitro activity of cephalosporin antibiotics.

Authors:  H C Neu
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

9.  Antibacterial activity of ceftizoxime, a beta-lactamase-stable cephalosporin.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

10.  Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria.

Authors:  M W Drulak; A W Chow
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191
View more
  2 in total

1.  Containing cefoxitin costs through a program to curtail use in surgical prophylaxis.

Authors:  G Taylor; E Blondel-Hill; P Kibsey; E Friesen; R Tisdell; W Vaudry
Journal:  Can J Infect Dis       Date:  1993-09

Review 2.  Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature.

Authors:  Shuming Jiang; Jianfei E; Dengchao Wang; Yanjiao Zou; Xiao Liu; Hualiang Xiao; Yuan Wen; Zongyao Chen
Journal:  Eur J Med Res       Date:  2021-09-20       Impact factor: 2.175
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.